Home › Melanoom › Utah › Salt Lake City
Melanoom klinische studies in Salt Lake City, UT
21 studies voor Melanoom zoeken deelnemers op locaties in en rond Salt Lake City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
RekruterenFase 2
- Huntsman Cancer Institute, Salt Lake City
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RekruterenFase 3
- University of Utah Huntsman Cancer Institute, Salt Lake City
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekruterenFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
RekruterenFase 3
- Intermountain Health, Salt Lake City
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
RekruterenFase 2
- Primary Children's Hospital, Salt Lake City
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RekruterenFase 1/2
- University of Utah - Huntsman Cancer Institute, Salt Lake City
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RekruterenFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruterenObservatieonderzoek
- Utah Cancer Specialists, Salt Lake City
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
RekruterenFase 1/2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Project: Every Child for Younger Patients With Cancer
RekruterenObservatieonderzoek
- Primary Children's Hospital, Salt Lake City
Rural Adult and Youth Sun Protection Study
RekruterenGezonde vrijwilligers welkom
- University of Utah, Salt Lake City
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruterenFase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
Rekruteren
- Huntsman Cancer Institute at The University of Utah, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruterenFase 1/2
- Huntsman Cancer Institute, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekruteren
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
RekruterenFase 3
- University of Utah Huntsman Cancer Institute, Salt Lake City
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
RekruterenFase 3
- Huntsman Cancer Institute, University of Utah 2000 Circle of Hope, Salt Lake City, UT
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
RekruterenFase 1/2
- Huntsman Cancer Institute, Salt Lake City
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
RekruterenFase 1/2
- Huntsman Cancer Institute - University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Salt Lake City
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekruteren
- Huntsman Cancer Institute (The University of Utah), Salt Lake City
Melanoom studies in andere steden
- Houston, TX59 studies
- New York City, NY38 studies
- Los Angeles, CA34 studies
- Nashville, TN33 studies
- Pittsburgh, PA31 studies
- Boston, MA26 studies
- Philadelphia, PA23 studies
- San Francisco, CA22 studies
- Columbus, OH21 studies
- Durham, NC21 studies
- Atlanta, GA21 studies
- St. Louis, MO21 studies
Andere studies in Salt Lake City
- Niet-kleincellige longkanker31 studies
- Kanker (alle vormen)27 studies
- Borstkanker27 studies
- Colorectale kanker22 studies
- Longkanker21 studies
- Multipel myeloom21 studies
- Metastatische kanker20 studies
- Eierstokkanker19 studies
- Obesitas18 studies
- Acute myeloïde leukemie17 studies
- Hartfalen17 studies
- Prostaatkanker15 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.